{
    "clinical_study": {
        "@rank": "163250", 
        "arm_group": {
            "arm_group_label": "Subjects who receive Arepanrix\u00ae", 
            "description": "Subjects who receive Arepanrix\u00ae as per routine practice"
        }, 
        "brief_summary": {
            "textblock": "This post-marketing surveillance study is designed to collect safety information such as\n      post-vaccination adverse events and adverse reactions from recipients of Arepanrix\u00ae (H1N1)\n      Intramuscular Injection.\n\n      The following items will be investigated as priority investigation items. <Priority\n      investigation items>\n\n        1. Allergic reactions\n\n        2. Anaphylaxis"
        }, 
        "brief_title": "Drug Use Investigation for Arepanrix\u00ae (H1N1)", 
        "completion_date": {
            "#text": "October 2010", 
            "@type": "Actual"
        }, 
        "condition": "Influenza", 
        "condition_browse": {
            "mesh_term": "Influenza, Human"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects who receive Arepanrix\u00ae intramuscular injection for the first time\n\n        Exclusion Criteria:\n\n          -  Not applicable"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Japanese subjects who receive Arepanrix\u00ae intramuscular injection for the first time"
            }
        }, 
        "enrollment": {
            "#text": "3405", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02069496", 
            "org_study_id": "114128"
        }, 
        "intervention": {
            "arm_group_label": "Subjects who receive Arepanrix\u00ae", 
            "description": "Injected according to the prescribing information in the locally approved label by the authorities.", 
            "intervention_name": "Arepanrix\u00ae", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 20, 2014", 
        "number_of_groups": "1", 
        "official_title": "Drug Use Investigation for Arepanrix\u00ae (H1N1)", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Japan: Pharmaceuticals and Medical Devices Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "The number of recipients who have adverse reactions after injection", 
                "safety_issue": "No", 
                "time_frame": "29 days"
            }, 
            {
                "measure": "The number of recipients who have post-vaccination adverse events after injection", 
                "safety_issue": "No", 
                "time_frame": "29 days"
            }, 
            {
                "measure": "The number of recipients who have allergic reactions after injection", 
                "safety_issue": "No", 
                "time_frame": "29 days"
            }, 
            {
                "measure": "The number of recipients who have anaphylaxis after injection", 
                "safety_issue": "No", 
                "time_frame": "29 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02069496"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2010", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2012"
    }
}